Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study.

Rypdal V, Arnstad ED, Aalto K, Berntson L, Ekelund M, Fasth A, Glerup M, Herlin T, Nielsen S, Peltoniemi S, Zak M, Rygg M, Rypdal M, Nordal E; Nordic Study Group of Pediatric Rheumatology (NoSPeR).

Arthritis Res Ther. 2018 May 3;20(1):91. doi: 10.1186/s13075-018-1571-6.

2.

The Finnish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Lahdenne P, Aalto K, Rebane K, Vahasalo P, Putto-Laurila AK, Malin M, Kroger L, Saila H, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):179-186. doi: 10.1007/s00296-018-3950-3. Epub 2018 Apr 7.

3.

Cryopyrin-associated periodic syndrome in early childhood can be successfully treated with interleukin-1 blockades.

Eskola V, Pohjankoski H, Kröger L, Aalto K, Latva K, Korppi M.

Acta Paediatr. 2018 Apr;107(4):577-580. doi: 10.1111/apa.14217. Epub 2018 Feb 5.

PMID:
29331074
4.

Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis.

Leinonen ST, Aalto K, Kotaniemi KM, Kivelä TT.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):1043-1046. Epub 2017 Nov 14.

PMID:
29148422
5.

Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study.

Nordal E, Rypdal V, Christoffersen T, Aalto K, Berntson L, Fasth A, Herlin T, Nielsen S, Peltoniemi S, Straume B, Zak M, Rygg M; Nordic Study Group of Pediatric Rheumatology (NoSPeR).

Pediatr Rheumatol Online J. 2017 Aug 18;15(1):66. doi: 10.1186/s12969-017-0195-8.

6.

Psoriasis and associated variables in classification and outcome of juvenile idiopathic arthritis - an eight-year follow-up study.

Ekelund M, Aalto K, Fasth A, Herlin T, Nielsen S, Nordal E, Peltoniemi S, Rygg M, Zak M, Berntson L; Nordic Study Group of Pediatric Rheumatology (NoSPeR).

Pediatr Rheumatol Online J. 2017 Feb 22;15(1):13. doi: 10.1186/s12969-017-0145-5.

7.

Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use.

Aalto K, Lahdenne P, Kolho KL.

Pediatr Rheumatol Online J. 2017 Jan 31;15(1):9. doi: 10.1186/s12969-016-0132-2.

8.

Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors.

Ahola-Olli AV, Würtz P, Havulinna AS, Aalto K, Pitkänen N, Lehtimäki T, Kähönen M, Lyytikäinen LP, Raitoharju E, Seppälä I, Sarin AP, Ripatti S, Palotie A, Perola M, Viikari JS, Jalkanen S, Maksimow M, Salomaa V, Salmi M, Kettunen J, Raitakari OT.

Am J Hum Genet. 2017 Jan 5;100(1):40-50. doi: 10.1016/j.ajhg.2016.11.007. Epub 2016 Dec 15.

9.

Deregulation of ocular nucleotide homeostasis in patients with diabetic retinopathy.

Loukovaara S, Sandholm J, Aalto K, Liukkonen J, Jalkanen S, Yegutkin GG.

J Mol Med (Berl). 2017 Feb;95(2):193-204. doi: 10.1007/s00109-016-1472-6. Epub 2016 Sep 16.

PMID:
27638339
10.

Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence.

Wang Q, Würtz P, Auro K, Morin-Papunen L, Kangas AJ, Soininen P, Tiainen M, Tynkkynen T, Joensuu A, Havulinna AS, Aalto K, Salmi M, Blankenberg S, Zeller T, Viikari J, Kähönen M, Lehtimäki T, Salomaa V, Jalkanen S, Järvelin MR, Perola M, Raitakari OT, Lawlor DA, Kettunen J, Ala-Korpela M.

Int J Epidemiol. 2016 Oct;45(5):1445-1457. Epub 2016 Aug 18.

11.

The Biomarker GlycA Is Associated with Chronic Inflammation and Predicts Long-Term Risk of Severe Infection.

Ritchie SC, Würtz P, Nath AP, Abraham G, Havulinna AS, Fearnley LG, Sarin AP, Kangas AJ, Soininen P, Aalto K, Seppälä I, Raitoharju E, Salmi M, Maksimow M, Männistö S, Kähönen M, Juonala M, Ripatti S, Lehtimäki T, Jalkanen S, Perola M, Raitakari O, Salomaa V, Ala-Korpela M, Kettunen J, Inouye M.

Cell Syst. 2015 Oct 28;1(4):293-301. doi: 10.1016/j.cels.2015.09.007. Epub 2015 Oct 22.

12.

[Special features of biological drug therapy in children].

Aalto K, Leinonen S, Kolho KL, Lahdenne P.

Duodecim. 2016;132(4):377-82. Review. Finnish.

PMID:
27017790
13.

Finding specific 10-joint Juvenile Arthritis Disease Activity Score (JADAS10) and clinical JADAS10 cut-off values for disease activity levels in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study.

Backström M, Tynjälä P, Ylijoki H, Aalto K, Kärki J, Pohjankoski H, Keskitalo P, Sard S, Hietanen M, Lehto H, Kauko T, Vähäsalo P.

Rheumatology (Oxford). 2016 Apr;55(4):615-23. doi: 10.1093/rheumatology/kev353. Epub 2015 Oct 7. Review.

PMID:
26447164
14.

Body composition and adipokines in patients with juvenile idiopathic arthritis and systemic glucocorticoids.

Markula-Patjas K, Valta H, Pekkinen M, Andersson S, Aalto K, Lahdenne P, Viljakainen H, Mäkitie O.

Clin Exp Rheumatol. 2015 Nov-Dec;33(6):924-30. Epub 2015 Aug 27.

PMID:
26315132
15.

Ankle arthritis predicts polyarticular disease course and unfavourable outcome in children with juvenile idiopathic arthritis.

Esbjörnsson AC, Aalto K, Broström EW, Fasth A, Herlin T, Nielsen S, Nordal E, Peltoniemi S, Rygg M, Zak M, Berntson L; Nordic Study Group of Paediatric Rheumatology (NoSPeR).

Clin Exp Rheumatol. 2015 Sep-Oct;33(5):751-7. Epub 2015 Jul 23.

PMID:
26213158
16.

Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis.

Jalkanen J, Yegutkin GG, Hollmén M, Aalto K, Kiviniemi T, Salomaa V, Jalkanen S, Hakovirta H.

Circ Res. 2015 Mar 27;116(7):1206-15. doi: 10.1161/CIRCRESAHA.116.305715. Epub 2015 Feb 2.

17.

Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis.

Weston CJ, Shepherd EL, Claridge LC, Rantakari P, Curbishley SM, Tomlinson JW, Hubscher SG, Reynolds GM, Aalto K, Anstee QM, Jalkanen S, Salmi M, Smith DJ, Day CP, Adams DH.

J Clin Invest. 2015 Feb;125(2):501-20. doi: 10.1172/JCI73722. Epub 2014 Dec 22.

18.

[Still's disease--juvenile arthritis with systemic onset].

Kröger L, Putto-Laurila A, Vähäsalo P, Malin M, Aalto K.

Duodecim. 2014;130(16):1615-21. Review. Finnish.

PMID:
25269367
19.

Early prediction of persistent organ failure by soluble CD73 in patients with acute pancreatitis*.

Maksimow M, Kyhälä L, Nieminen A, Kylänpää L, Aalto K, Elima K, Mentula P, Lehti M, Puolakkainen P, Yegutkin GG, Jalkanen S, Repo H, Salmi M.

Crit Care Med. 2014 Dec;42(12):2556-64. doi: 10.1097/CCM.0000000000000550.

PMID:
25126879
20.

Distribution and medical impact of loss-of-function variants in the Finnish founder population.

Lim ET, Würtz P, Havulinna AS, Palta P, Tukiainen T, Rehnström K, Esko T, Mägi R, Inouye M, Lappalainen T, Chan Y, Salem RM, Lek M, Flannick J, Sim X, Manning A, Ladenvall C, Bumpstead S, Hämäläinen E, Aalto K, Maksimow M, Salmi M, Blankenberg S, Ardissino D, Shah S, Horne B, McPherson R, Hovingh GK, Reilly MP, Watkins H, Goel A, Farrall M, Girelli D, Reiner AP, Stitziel NO, Kathiresan S, Gabriel S, Barrett JC, Lehtimäki T, Laakso M, Groop L, Kaprio J, Perola M, McCarthy MI, Boehnke M, Altshuler DM, Lindgren CM, Hirschhorn JN, Metspalu A, Freimer NB, Zeller T, Jalkanen S, Koskinen S, Raitakari O, Durbin R, MacArthur DG, Salomaa V, Ripatti S, Daly MJ, Palotie A; Sequencing Initiative Suomi (SISu) Project.

PLoS Genet. 2014 Jul 31;10(7):e1004494. doi: 10.1371/journal.pgen.1004494. eCollection 2014 Jul.

21.

Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA).

Berntson L, Nordal E, Fasth A, Aalto K, Herlin T, Nielsen S, Rygg M, Zak M, Rönnelid J; Nordic Study Group of Pediatric Rheumatology (NoSPeR).

Pediatr Rheumatol Online J. 2014 Jun 11;12:22. doi: 10.1186/1546-0096-12-22. eCollection 2014.

22.

Soluble vascular adhesion protein-1 predicts incident major adverse cardiovascular events and improves reclassification in a finnish prospective cohort study.

Aalto K, Havulinna AS, Jalkanen S, Salomaa V, Salmi M.

Circ Cardiovasc Genet. 2014 Aug;7(4):529-35. doi: 10.1161/CIRCGENETICS.113.000543. Epub 2014 May 21.

23.

Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis.

Nousiainen P, Merras-Salmio L, Aalto K, Kolho KL.

BMC Complement Altern Med. 2014 Apr 4;14:124. doi: 10.1186/1472-6882-14-124.

24.

HLA-B27 predicts a more chronic disease course in an 8-year followup cohort of patients with juvenile idiopathic arthritis.

Berntson L, Nordal E, Aalto K, Peltoniemi S, Herlin T, Zak M, Nielsen S, Rygg M; Nordic Study Group of Paediatric Rheumatology.

J Rheumatol. 2013 May;40(5):725-31. doi: 10.3899/jrheum.121257. Epub 2013 Apr 1.

PMID:
23547219
25.

Prevention of infusion reactions to infliximab in paediatric patients with oral acetylsalicylic acid.

Hämäläinen A, Lahdenne P, Wikström A, Aalto K, Kolho KL.

Clin Exp Rheumatol. 2012 Jul-Aug;30(4):590-1. Epub 2012 Aug 29. No abstract available.

PMID:
22766212
26.

[Medical treatment of juvenile idiopathic arthritis].

Kröger L, Vähäsalo P, Tynjälä P, Aalto K, Säilä H, Malin M, Putto-Laurila A, Lahdenne P.

Duodecim. 2012;128(5):477-86. Review. Finnish.

PMID:
22486063
27.

Validity and predictive ability of the juvenile arthritis disease activity score based on CRP versus ESR in a Nordic population-based setting.

Nordal EB, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, Lahdenne P, Nielsen S, Peltoniemi S, Straume B, Rygg M.

Ann Rheum Dis. 2012 Jul;71(7):1122-7. doi: 10.1136/annrheumdis-2011-200237. Epub 2012 Jan 17.

PMID:
22258487
28.

Soluble vascular adhesion protein-1 correlates with cardiovascular risk factors and early atherosclerotic manifestations.

Aalto K, Maksimow M, Juonala M, Viikari J, Jula A, Kähönen M, Jalkanen S, Raitakari OT, Salmi M.

Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):523-32. doi: 10.1161/ATVBAHA.111.238030. Epub 2011 Nov 23.

29.

Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer.

Aalto K, Autio A, Kiss EA, Elima K, Nymalm Y, Veres TZ, Marttila-Ichihara F, Elovaara H, Saanijoki T, Crocker PR, Maksimow M, Bligt E, Salminen TA, Salmi M, Roivainen A, Jalkanen S.

Blood. 2011 Sep 29;118(13):3725-33. doi: 10.1182/blood-2010-09-311076. Epub 2011 Aug 5.

30.

Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.

Tynjälä P, Vähäsalo P, Tarkiainen M, Kröger L, Aalto K, Malin M, Putto-Laurila A, Honkanen V, Lahdenne P.

Ann Rheum Dis. 2011 Sep;70(9):1605-12. doi: 10.1136/ard.2010.143347. Epub 2011 May 28.

PMID:
21623000
31.

Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis.

Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, Lahdenne P, Nielsen S, Straume B, Rygg M; Nordic Study Group of Pediatric Rheumatology.

Arthritis Rheum. 2011 Sep;63(9):2809-18. doi: 10.1002/art.30426.

32.

Iron status during anti-TNF therapy in children with juvenile idiopathic arthritis.

Aalto K, Honkanen V, Lahdenne P.

Clin Rheumatol. 2011 Jan;30(1):115-9. doi: 10.1007/s10067-010-1571-7. Epub 2010 Sep 30.

PMID:
20882311
33.

Prevention of acute adverse events related to infliximab infusions in pediatric patients.

Lahdenne P, Wikström AM, Aalto K, Kolho KL.

Arthritis Care Res (Hoboken). 2010 Jun;62(6):785-90. doi: 10.1002/acr.20246.

34.

Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate.

Kivi E, Elima K, Aalto K, Nymalm Y, Auvinen K, Koivunen E, Otto DM, Crocker PR, Salminen TA, Salmi M, Jalkanen S.

Blood. 2009 Dec 17;114(26):5385-92. doi: 10.1182/blood-2009-04-219253. Epub 2009 Oct 27.

35.

The mechanism of primary patellar dislocation: trauma history of 126 patients.

Nikku R, Nietosvaara Y, Aalto K, Kallio PE.

Acta Orthop. 2009 Aug;80(4):432-4. doi: 10.3109/17453670903110634.

36.

Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis.

Tynjälä P, Kotaniemi K, Lindahl P, Latva K, Aalto K, Honkanen V, Lahdenne P.

Rheumatology (Oxford). 2008 Mar;47(3):339-44. doi: 10.1093/rheumatology/kem356. Epub 2008 Jan 31.

PMID:
18238789
37.

Assessment of disease activity in juvenile idiopathic arthritis. The number and the size of joints matter.

Berntson L, Wernroth L, Fasth A, Aalto K, Herlin T, Nielsen S, Nordal E, Rygg M, Zak M.

J Rheumatol. 2007 Oct;34(10):2106-11. Epub 2007 Sep 15.

PMID:
17896798
38.

Bone health and growth in glucocorticoid-treated patients with juvenile idiopathic arthritis.

Valta H, Lahdenne P, Jalanko H, Aalto K, Mäkitie O.

J Rheumatol. 2007 Apr;34(4):831-6. Epub 2007 Feb 15.

PMID:
17309121
39.
41.

Nerve growth factor in serum of children with systemic lupus erythematosus is correlated with disease activity.

Aalto K, Korhonen L, Lahdenne P, Pelkonen P, Lindholm D.

Cytokine. 2002 Nov 7;20(3):136-9.

PMID:
12453472
43.

[Abdominal pain in a young woman].

Aalto K, Hulmi T.

Duodecim. 1999;115(18):2023,2027. Finnish. No abstract available.

PMID:
11963924
44.

Lactate inhibits germ cell apoptosis in the human testis.

Erkkilä K, Aito H, Aalto K, Pentikäinen V, Dunkel L.

Mol Hum Reprod. 2002 Feb;8(2):109-17.

PMID:
11818513
45.

Tsunami(?) Sculpturing of the Pebble Beach Wave-Cut Platform, Crescent City Area, California.

Aalto KR, Aalto R, Garrison-Laney CE, Abramson HF.

J Geol. 1999 Sep;107(5):607-622.

PMID:
10504138
46.

Operative versus closed treatment of primary dislocation of the patella. Similar 2-year results in 125 randomized patients.

Nikku R, Nietosvaara Y, Kallio PE, Aalto K, Michelsson JE.

Acta Orthop Scand. 1997 Oct;68(5):419-23.

PMID:
9385238
47.

Serum C-reactive protein, erythrocyte sedimentation rate and white blood cell count in septic arthritis of children.

Kallio MJ, Unkila-Kallio L, Aalto K, Peltola H.

Pediatr Infect Dis J. 1997 Apr;16(4):411-3. No abstract available.

PMID:
9109146
48.

The cartilaginous femoral sulcus in children with patellar dislocation: an ultrasonographic study.

Nietosvaara Y, Aalto K.

J Pediatr Orthop. 1997 Jan-Feb;17(1):50-3.

PMID:
8989701
49.
50.

Mitochondrial superoxide dismutase induction does not protect epithelial cells during oxidant exposure in vitro.

Kinnula VL, Pietarinen P, Aalto K, Virtanen I, Raivio KO.

Am J Physiol. 1995 Jan;268(1 Pt 1):L71-7.

PMID:
7840231

Supplemental Content

Support Center